Novo Nordisk reported DKK45.65B in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Bausch Health Companies USD 1.6B 1000K Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Merck USD 6.21B 272M Jun/2026
Novartis USD 6.22B 66M Jun/2026
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Novo Nordisk DKK 51.35B 8.5B Mar/2026
Pacira USD 134.57M 15.8M Jun/2026
Sanofi EUR 24.12B 620M Jun/2026
Supernus Pharmaceuticals USD 107.03M 3.74M Jun/2026